Arvest Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$13.9M Sell
95,328
-4,064
-4% -$604K 0.83% 42
2024
Q1
$15.7M Sell
99,392
-3,353
-3% -$534K 0.89% 38
2023
Q4
$16.1M Sell
102,745
-3,598
-3% -$552K 0.97% 35
2023
Q3
$16.6M Sell
106,343
-1,084
-1% -$179K 1.08% 29
2023
Q2
$18M Sell
107,427
-3,789
-3% -$612K 1.07% 27
2023
Q1
$17.2M Sell
111,216
-1,253
-1% -$202K 1.07% 27
2022
Q4
$19.9M Sell
112,469
-6,691
-6% -$1.16M 1.25% 22
2022
Q3
$19.5M Buy
119,160
+1,525
+1% +$258K 1.34% 19
2022
Q2
$20.9M Sell
117,635
-4,946
-4% -$881K 1.37% 20
2022
Q1
$21.7M Sell
122,581
-1,253
-1% -$213K 1.21% 28
2021
Q4
$21.2M Buy
+123,834
New +$20.3M 1.12% 30
2014
Q2
$16.8M Sell
160,451
-402
-0.2% -$40.6K 1.55% 15
2014
Q1
$16.3M Sell
160,853
-1,871
-1% -$173K 1.57% 15
2013
Q4
$14.9M Sell
162,724
-4,143
-2% -$382K 1.48% 22
2013
Q3
$14.5M Sell
166,867
-1,351
-0.8% -$121K 1.58% 22
2013
Q2
$14.4M Buy
+168,218
New +$14.3M 1.65% 22

Other funds holding JNJ

Arvest Trust's JNJ Position: Q2 2024 in Review

Arvest Trust reduced its Johnson & Johnson (JNJ) stake by 4.1% in Q2 2024, selling an estimated $604K and leaving 95,328 shares worth $13.9M. The position accounts for 0.83% of the portfolio, ranked #42.

Arvest Trust first reported a position in JNJ in Q2 2013 and has held it in 16 quarters since. The position peaked at $21.7M in Q1 2022. 3,802 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • Arvest Trust held 95,328 shares of Johnson & Johnson worth $13.9M as of Q2 2024.
  • Arvest Trust sold 4,064 Johnson & Johnson shares in Q2 2024, an estimated $604K.
  • Johnson & Johnson made up 0.83% of Arvest Trust's portfolio in Q2 2024, its #42 holding.
  • Arvest Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 16 quarters since.
  • Arvest Trust's Johnson & Johnson position peaked at $21.7M in Q1 2022.
  • 3,802 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Arvest Trust's 13F filing for Q2 2024, filed 9 Aug 2024.